These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Molecular modeling: a tool for predicting anthelmintic activity in vivo. Lipkowitz KB, McCracken RO. Parasitol Res; 1993; 79(6):475-9. PubMed ID: 8415561 [Abstract] [Full Text] [Related]
5. Anthelmintic-induced destrobilation and its influence on calculated drug efficacy in Hymenolepis diminuta infections in rats. Dixon BR, Arai HP. J Parasitol; 1991 Oct; 77(5):769-74. PubMed ID: 1919927 [Abstract] [Full Text] [Related]
6. Water balance and its relation to fermentation acid production in the intestinal parasites Hymenolepis diminuta (Cestoda) and Moniliformis moniliformis (Acanthocephala). Uglem GL. J Parasitol; 1991 Dec; 77(6):874-83. PubMed ID: 1779290 [Abstract] [Full Text] [Related]
7. Efficacy of albendazole and mebendazole against Hymenolepis microstoma and Hymenolepis diminuta. McCracken RO, Lipkowitz KB, Dronen NO. Parasitol Res; 1992 Dec; 78(2):108-11. PubMed ID: 1557321 [Abstract] [Full Text] [Related]
8. Infectivity of Hymenolepis diminuta for the jird, Meriones unguiculatus, and utility of this model for anthelmintic studies. Johnson SS, Conder GA. J Parasitol; 1996 Jun; 82(3):492-5. PubMed ID: 8636859 [Abstract] [Full Text] [Related]
13. Hymenolepis diminuta: effects of amoscanate on energy metabolism and ultrastructure. Nelson NF, Saz HJ. Exp Parasitol; 1983 Aug; 56(1):55-69. PubMed ID: 6409659 [Abstract] [Full Text] [Related]
14. Anticestodal activity of Adhatoda vasica extract against Hymenolepis diminuta infections in rats. Yadav AK, Tangpu V. J Ethnopharmacol; 2008 Sep 26; 119(2):322-4. PubMed ID: 18691645 [Abstract] [Full Text] [Related]
15. [Screening of compounds active at the larval stage of Hymenolepis nana]. Krotov AI, Baiandina DG, Bekhli AF, Braude MB, Kozyreva NP. Med Parazitol (Mosk); 1974 Sep 26; 43(6):697-700. PubMed ID: 4449524 [No Abstract] [Full Text] [Related]
16. The effect of praziquantel on Hymenolepis diminuta in vitro. Andrews P, Thomas H. Tropenmed Parasitol; 1979 Sep 26; 30(3):391-400. PubMed ID: 543005 [Abstract] [Full Text] [Related]
17. Dose-dependent activity of albendazole against benzimidazole-resistant nematodes in sheep: relationship between pharmacokinetics and efficacy. Moreno L, Echevarria F, Muñoz F, Alvarez L, Sanchez Bruni S, Lanusse C. Exp Parasitol; 2004 Sep 26; 106(3-4):150-7. PubMed ID: 15172222 [Abstract] [Full Text] [Related]
18. Comparative activity of anthelmintic drugs, mebendazole, praziquantel and albendazole against Hymenolepis diminuta in experimentally infected rats. Galal M, Chin SR. Rev Elev Med Vet Pays Trop; 1987 Sep 26; 40(2):147-50. PubMed ID: 3453505 [No Abstract] [Full Text] [Related]
19. In vivo effects of putative crowding factors on development of Hymenolepis diminuta. Cook RL, Roberts LS. J Parasitol; 1991 Feb 26; 77(1):21-5. PubMed ID: 1846915 [Abstract] [Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program . Natl Toxicol Program Tech Rep Ser; 1993 Sep 26; 422():1-340. PubMed ID: 12616289 [Abstract] [Full Text] [Related] Page: [Next] [New Search]